betulinic acid has been researched along with Bladder Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheong, J; Choi, YH; Hwangbo, H; Ji, SY; Kim, DH; Kim, GY; Kim, MY; Kim, SY; Kim, WJ; Lee, H; Leem, SH; Moon, SK; Park, C; Yun, SJ | 1 |
Burghardt, R; Chadalapaka, G; Jutooru, I; Safe, S | 1 |
2 other study(ies) available for betulinic acid and Bladder Cancer
Article | Year |
---|---|
Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Caspase 3; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Humans; In Vitro Techniques; Neoplasm Metastasis; Pentacyclic Triterpenes; Reactive Oxygen Species; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2021 |
Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.
Topics: Antineoplastic Agents; Autophagy; Betulinic Acid; Curcumin; Down-Regulation; Drug Delivery Systems; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Microtubule-Associated Proteins; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-akt; RNA Stability; RNA, Small Interfering; Sp Transcription Factors; Sp1 Transcription Factor; Sp3 Transcription Factor; Triterpenes; Urinary Bladder Neoplasms | 2010 |